Nicotine enhances morphine- and β-endorphin-induced antinociception at the supraspinal level in the mouse

Neuropeptides

Volumn 30, Issue 5, 1996, Pages 479-484

  Suh, H W ^a   Song, D K ^a   Choi, S R ^a   Chung, K M ^a   Kim, Y H ^a  

^a Hallym University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BETA ENDORPHIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; MORPHINE; NICOTINE; NICOTINIC RECEPTOR; OPIATE AGONIST;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST;

ANIMALIA;

EID: 0029965588     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(96)90013-X     Document Type: Article

References (39)

1. Sahley TL, Bernston GG. Antinociceptive effects of central and systemic administration of nicotine in the rat. Psychopharmacology 1979; 65: 279-283.
2. Aceto MD, Awaya H, Martin BR, May EL. Antinociceptive action of nicotine and its methiodide derivatives in mice and rats. Br J Pharmacol 1983; 79: 869-876.
3. Aceto MD, Bagley RS, Dewey WL, Fu TC, Martin BR. The spinal cord as a major site for the antinociceptive action of nicotine in the rat. Neuropharmacology 1986; 25: 1031-1036.
4. Martin WR, Kumar S, Sloan JW. Opioid and nicotinic medullary hyperalgesic influences in the decerebrated rat. Pharmacol Biochem Behav 1988; 29: 725-731.
5. Iwamoto ET. Characterization of the antinociception induced by nicotine in the pedunculopontine tegmental nucleus and nucleus raphe magnus. J Pharmacol Exp Ther 1991; 257: 120-133.
6. Hamann SR, Martin WR. Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem. J Pharmacol Exp Ther 1992; 261: 707-715.
7. Yang CY, Wu WH, Zbuzek VK. Antinociceptive effect of chronic nicotine and nociceptive effect of its withdrawal measured by hot-plate and tail-flick in rats. Psychopharmacology 1992; 106: 417-420.
8. Block RC, Chin CWY, Wu WH, Zbuzek VK. Nicotine-induced analgesia in rats: the role of calcium and the diversity of responders and nonresponders. Life Sci 1993; 53: PL 195-200.
9. Damaj MI, Welch SP, Martin BR. Nicotine-induced antinociception in mice: role of G-proteins and adenylate cyclase. Pharmacol Biochem Behav 1994; 48: 37-42.
10. Kuraishi Y, Fukui K, Shiomi H, Akaike A, Takagi H. Microinjection of opioids into the nucleus reticularis gigantocellularis of the rat: analgesia and increase in the normetanephrine level in the spinal cord. Biochem Pharmacol 1978; 27: 2756-2758.
11. Kuraishi Y, Darada Y, Takagi H. Noradrenaline regulation of pain-transmission in the spinal cord mediated by alpha-adrenoceptors. Brain Res 1979; 174: 333-336.
12. Kuraishi Y, Harada Y, Aratani S, Satoh M, Takagi H. Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the difference in mechanical and thermal analgesic tests. Brain Res 1983; 273: 245-252.
13. Yaksh TL. Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effect of morphine in the periaqueductal gray. Brain Res 1979; 160: 180-185.
14. 5-enkephalin-and U50, 488H-induced analgesia in mice. Neuropharmacology 1988; 27: 957-963.
15. Suh HH, Fujimoto JM, Tseng LF. Differential mechanisms mediating β-endorphin- and morphine-induced analgesia in mice. Eur J Pharmacol 1989; 168: 61-70.
16. Wigdor S, Wilcox GL. Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J Pharmacol Exp Ther 1987; 242: 90-95.
17. Jung JS, Song DK, Choi YS, Kim YH. Effects of intraventricular injection of morphine and β-endorphin on serotonin release from the spinal cord in rats. Pharmacol Biochem Behav 1994; 49: 1037-1042.
18. Tseng LF, Higgins MJ, Hong JS, Hudson PM, Fujimoto JM. Release of immunoreactive Met-enkephalin from the spinal cord by intraventricular β-endorphin but not morphine in anesthetized rats. Brain Res 1985; 343: 60-69.
19. Tseng LF, King RC, Fujimoto JM. Release of immunoreactive Met-enkephalin by intraventricular β-endorphin in anesthetized rats. Reg Pept 1986; 14: 181-192.
20. Suh HH, Collins KA, Tseng LF. Intrathecal cholecystokinin octapeptide attenuates the antinociception and release of immunoreactive Met-enkephalin induced by intraventricular β-endorphin in the rat. Neuropeptides 1992; 21: 131-137.
21. 4-Gly-ol-enkephalin against β-chlornaltrexamine in the spinal cord on the antinociception induced by β-endorphin administered intracerebroventricularly in the mouse. Neuropeptides 1994; 27: 143-149.
22. Suh HH, Tseng LF. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by β-endorphin given intracerebroventricularly in mice. J Pharmacol Exp Ther 1990; 253: 981-986.
23. Suh HH, Tseng LF. Tolerance to δ- but not μ-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by β-endorphin administered intracerebroventricularly. Pharmacol Biochem Behav 1990; 35: 807-813.
24. 5]enkephalin antibody blocks analgesia induced by intracerebroventricular β-endorphin but not morphine in mice. Eur J Pharmacol 1989; 173: 171-176.
25. Tseng LF, Collins KA. Involvement of epsilon and kappa opioid receptors in inhibition of the tail-flick response induced by bremazocine in the mouse. J Pharmacol Exp Ther 1991; 260: 1086-1093.
26. Piezchala K, Houdi AA, Van Loon GR. Nicotine-induced alterations in brain regional concentrations of native and cryptic M.et- and Leu-enkephalin. Peptides 1987; 8: 1035-1043.
27. Davenport KE, Houdi AA, Van Loon GR. Nicotine protects against μ-opioid receptor antagonism by β-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain. Neurosci Lett 1990; 113: 40-46.
28. Eiden LE, Giraud P, Dave JT, Hotchkiss AJ, Affolter H. Nicotine receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells. Nature 1984; 312: 661-663.
29. 5]-enkephalin in bovine adrenal medullary chromaffin cells. J Pharmacol Exp Ther 1995; 275: 1663-1670.
30. Wewers ME, Tejwani GA, Anderson J. Plasma nicotine, plasma β-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement. Psychopharmacology 1994; 116: 98-102.
31. D'Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941; 72: 74-79.
32. Haley TJ, McCormick WG. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol 1957; 12: 12-15.
33. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose effect experiments. J Pharmacol Exp Ther 1949; 96: 99-113.
34. Tallarida LF, Murray RB. Manual of Pharmacologic Calculations with Computer Programs. New York: Springer-Verlag, 1981.
35. Roerig SC, Fujimoto JM, Tseng LF. Comparisons of descending pain inhibitory pathways activated by β-endorphin and morphine as characterized by supraspinal and spinal antinociceptive interactions in mice. J Pharmacol Exp Ther 1988; 247: 1107-1113.
36. Roerig SC, Lei S, Kitto K, Hylden JKL, Wilcox GL. Spinal interactions between opioid and noradrenergic agonists in mice: Multiplicativity involves delta and alpha-2 receptors. J Pharmacol Exp Ther 1992; 262: 365-374.
37. Suh HH, Tseng LR Intrathecal β-funaltrexamine antagonizes intracerebroventricular β-endorphin- but not morphineinduced analgesia in mice. J Pharmacol Exp Ther 1988; 245: 587-593.
38. Suh HH, Tseng LF. Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and β-endorphin in mice. Naunyn-Schmiedeberg's Arch Pharmacol 1990; 342: 67-71.
39. Suh HH, Tseng LF. Lack of antinociceptive cross-tolerance between intracerebroventricularly administered β-endorphin and morphine or DPDPE in mice. Life Sci 1990; 46: 759-765.